During the scientific conference, magAssistDr. Rui Wang from Academician Junbo Ge's TeamShared NyokAssist^®Preliminary Results of a Prospective, Multicenter, Randomized Controlled Clinical Trial of a Transcatheter Ventricular Assist Device. The device isThe team of Academician Ge Junbo from Zhongshan Hospital, Shanghai, and magAssist (Suzhou) Co., Ltd. ("magAssist" for short)A new generation of interventional pump that responds to the call of the country and achieves integrated innovation through medical-engineering convergence.

This study is a prospective, multicenter, randomized controlled trial planning to enroll over 200 patients with left ventricular ejection fraction (EF) ≤40% or those scheduled for high-risk PCI (HR-PCI), including interventions on unprotected left main coronary arteries, the last remaining open coronary artery, or triple-vessel disease. Participants will be randomized in a 1:1 ratio to receive the NyokAssist.^®and intra-aortic balloon pump (IABP), aimed to evaluate NyokAssist^®Safety and Efficacy of Cardiovascular Hemodynamic Support in HR-PCI Patients.

Preliminary research results show,NyokAssist^®There were no significant differences between the two groups in terms of major adverse cardiovascular and cerebrovascular events (MACCE), mortality, target vessel revascularization, neurological complications (stroke/TIA), myocardial infarction (MI), renal complications, major vascular complications, and the incidence of hypotension during the support period at the time of hospitalization, 30 days post-operation, and 90 days post-operation. This suggests that NyokAssist^®Its application in high-risk PCI patients is safe.

Dr. Wang Rui pointed out, NyokAssist^®NyokAssist is a foldable, externally driven micro axial flow pump designed for safe insertion through a 9Fr arterial access, providing a flow rate of up to 5L/min. Early study results show a low complication rate, with encouraging outcomes. However, further research and analysis of more patients are needed to gain a deeper understanding of NyokAssist.^®Safety and Efficacy of IABP in High-Risk PCI.